VERISIM
Verisim provide unique software simulation solutions for Training, Prototyping and Customer Demonstration across the project lifecycle. Verisim is best placed to assist you if; A new application needs to be delivered on time, on budget and on spec; Employees need to be trained on an application as early, safely and efficiently as possible; Communication is required to educate customers on the benefits of online services without any risk to their own account; You are implementing Temenos T24 core banking software.
VERISIM
Industry:
Financial Services Information Technology Software
Founded:
2001-01-01
Address:
Edinburgh, Edinburgh, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.verisim.com
Total Employee:
11+
Status:
Active
Contact:
+44 1383 428059
Email Addresses:
[email protected]
Total Funding:
3 M GBP
Technology used in webpage:
U.S. Server Location Akamai
Similar Organizations
abraxas GmbH
abraxas GmbH offers software solutions for banks and financial service providers.
CAD IT SpA
CAD IT is an IT firm offering software solutions in the field of banking and financial services and other financial services.
SilverBridge
SilverBridge Holdings is an AltX- listed company with full ownership and control of SilverBridge.
Vialogue
Developing Conversational Software (Voice and Text) primarly for companies in the financial services sector.
Current Employees Featured
Investors List
Cazenove Capital
Cazenove Capital investment in Venture Round - Verisim
Scottish Equity Partners
Scottish Equity Partners investment in Venture Round - Verisim
Official Site Inspections
http://www.verisim.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Verisim"
VeriSIM Life | AI Drug Discovery & Development
Our AI-driven drug development services deliver insights for pharmaceutical companies, biotechs, and academic & research institutions. We also partner in risk-sharing collaborations to develop …See details»
Meaningful outcomes powered by BIOiSIM - VeriSIM Life
Our “hybrid AI” platform, BIOiSIM ®, and its groundbreaking Translational Index® technology, are helping de-risk drug design and development – bringing more successful therapies from the scientist’s bench to the patient’s bedside.See details»
Patient stratification - VeriSIM Life
VeriSIM Life’s groundbreaking drug decision engine, BIOiSIM®, uses AI-driven diagnostics and screening techniques to greatly enhance traditional patient stratification methods while …See details»
VeriSIM Life - Crunchbase Company Profile & Funding
VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials. VeriSIM offers a range of translational-based solutions, customized for the pre …See details»
BIOiSIM offers predictive AI capabilties for drug …
Feb 8, 2024 · VeriSIM Life, a San Francisco-based startup, has created BIOiSIM, an AI-powered platform that simulates drug compound behavior in the human body by acting like a virtual laboratory. It assigns each a predictive “credit …See details»
VeriSIM Life - LinkedIn
VeriSIM Life is building AI enabled biosimulation models. VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow,...See details»
VeriSIM Life Enters into Collaboration Agreement with …
Jun 28, 2022 · VeriSIM will engage Mayo Clinic physician researchers in key disease areas including oncology, hematology, bone/joint-disorders, and neurological diseases.See details»
VeriSIM Life - VentureRadar
Website: http://verisimlife.com Develops a drug decision engine using AI and ML techniques, reducing time, cost, and animal testing in pharmaceutical development while optimizing …See details»
VeriSIM Life: This Company Is Building AI-Enabled …
Oct 17, 2023 · VeriSIM Life is a company that is building AI-enabled biosimulation models. And VeriSIM is tackling one of the biggest obstacles to drug development: animal testing for drug development.See details»
Drug Formulation - VeriSIM Life
VeriSIM Life (VSL)’s drug decision engine, BIOiSIM®, is a computational platform deploying advanced artificial intelligence and machine learning, a proprietary big data foundation, and …See details»
VeriSIM Life Company Profile 2024: Valuation, Funding ... - PitchBook
Developer of a disease-specific simulation software designed to replace animal drug testing by using artificial intelligence.See details»
VeriSIM Life's AI platform wants to speed up drug discovery
Jul 22, 2024 · Earlier this year, VeriSIM introduced a new feature to the platform, AtlasGEN, focused on providing biological translation simulations — estimates of how well a drug actually …See details»
VeriSIM Life - Craft
VeriSIM Life is a company that provides drug discovery and development technology solutions. It develops BIOiSIM, a platform used before preclinical animal trials start. The company offers …See details»
VeriSIM Life Secures a Federal Grant to Create a Drug …
Mar 2, 2021 · VeriSIM Life has developed a whole-body biosimulation platform driven by AI and machine learning (ML), that accurately predicts the clinical efficacy of new drugs before human …See details»
VeriSIM Life: Using AI to build translational indices to push better ...
Apr 4, 2023 · Jo Varshney, Ph.D., is the founder and CEO of VeriSIM Life, a startup developing disease-specific simulation software designed to replace animal drug testing by using artificial …See details»
About us | Diversity, Inclusion, and Belonging | VeriSIM Life
We are a dedicated team of scientists, modelers, chemists and software engineers that are passionate about addressing the need for better prediction in healthcare. VeriSIM was …See details»
VeriSIM Life and Total Brain Announce Strategic ... - Business Wire
May 26, 2022 · VeriSIM Life has developed a sophisticated computational platform that leverages advanced AI and ML techniques to improve drug discovery and development by significantly …See details»
Our Pipeline - verisimlife.com
By expanding our pipeline with precision-driven assets across diverse diseases, VeriSIM Life is advancing a powerful, scalable approach to drug development that addresses urgent patient …See details»
VeriSIM Life Secures $15 Million Series A Funding
Jan 6, 2022 · VeriSIM’s BIOiSIM platform, driven by artificial intelligence (AI) and machine learning (ML), de-risks R&D decisions by providing meaningful insights much earlier in the …See details»
VeriSIM Life launches PulmoSIM Therapeutics to Develop …
Mar 22, 2021 · PulmoSIM is developing breakthrough therapies for rare and progressive respiratory diseases to improve patient outcomes and quality of life. PulmoSIM’s approach …See details»